Beta interferon, an anti-inflammatory drug that has already been approved for treatment of multiple sclerosis, is being paired with remdesivir in the latest phase of a federal coronavirus trial, The New York Times reports.
The remdesivir-focused study has found it can quicken the recovery time of COVID-19 patients, but researchers are seeking to boost its effects by combining it with other treatments. Beta interferon is the second drug to get the call — the results of the study's second phase which involved an anti-inflammatory arthritis drug are still being evaluated — and scientists are hopeful, per the Times.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
-
'Make legal immigration a more plausible option'Instant Opinion Opinion, comment and editorials of the day
-
LA-to-Las Vegas high-speed rail line breaks groundSpeed Read The railway will be ready as soon as 2028
-
Israel's military intelligence chief resignsSpeed Read Maj. Gen. Aharon Haliva is the first leader to quit for failing to prevent the Hamas attack in October
-
Texas dairy worker gets bird flu from infected cowSpeed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
-
Dengue hits the Americas hard and earlySpeed Read Puerto Rico has declared an epidemic as dengue cases surge
-
US bans final type of asbestosSpeed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical recordsSpeed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
-
Afghanistan has a growing female suicide problemSpeed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
-
US life expectancy rose in 2022 but not to pre-pandemic levelsSpeed Read Life expectancy is slowly crawling back up
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid scienceSpeed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
-
An increasing number of dog owners are 'vaccine hesitant' about rabiesSpeed Read A new survey points to canine vaccine hesitancy
